Mark Hopman Insider Trades & Stock Holdings

Chief Commercial Officer · Beta Bionics, Inc. · Latest filing Oct 14, 2026

Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc. has 1 Form 4 trade on file since Oct 14, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($13.45K), net -$13.45K. Latest filing: disposed of 775 shares of $BBNX on Oct 14, 2026 at $17.35.

Trades on file

1

Open-market bought

$0

Open-market sold

$13.45K

Net open-market

-$13.45K

Shares held ($BBNX)

55.33K

Latest filing

Oct 14, 2026

Shares held by Mark Hopman

• $BBNX55.33K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Mark Hopman

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 14, 2026	$BBNX	Sell (Open-market sale) 10b5-1	775	$17.35	$13.45K	55.33K	-1.38%				Chief Commercial Officer	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Mark Hopman traded

• $BBNX

Frequently asked questions

Has Mark Hopman been buying or selling stock?

Mark Hopman has 0 open-market purchases and 1 open-market sale on file, net -$13.45K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Mark Hopman's latest insider trade?

disposed of 775 shares of $BBNX on Oct 14, 2026 at $17.35.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.